Associate/Sr. Associate, Life Sciences (Abingworth)
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Abingworth is a leading transatlantic life sciences investment firm. The firm is focused on transforming cutting-edge science into novel medicines by providing capital and expertise to top-caliber management teams building world-class private and publicly traded companies. Since 1973, Abingworth has raised 15 funds and invested in 187 life science companies, leading to 50 M&As and 76 IPOs. The firm's strategic approach is broad with therapeutic focused investments falling into 3 categories: Seed and early-stage, Development stage (including some companies that are publicly traded), Clinical co-development programs with major pharmaceutical companies. The firm invests across therapeutic modalities including biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, specialty pharma, gene therapies, cell therapies and platform technologies. In August 2022, The Carlyle Group acquired Abingworth to bolster Carlyle's leading global healthcare franchise and to operate across the full risk-return spectrum of life sciences and healthcare investing. Abingworth supports its portfolio companies across 3 key biotech centers: Boston, London, and Menlo Park. In addition to investment expertise from the team of investment professionals, the Abingworth team collectively brings deep knowledge and skills across research & development, business development, corporate finance, recruitment, legal, public relations and operations. The team is further complemented by an extensive international network of scientific, clinical and industry experts who participate in the deal sourcing and evaluation process. Abingworth is well resourced to assist companies at any stage of development, and Partners of the firm play an active role on the Boards of portfolio companies.
